APIXABAN FOR THE REDUCTION OF THROMBO-EMBOLISM IN PATIENTS WITH DEVICE-DETECTED SUB-CLINICAL ATRIAL FIBRILLATION

Upcoming Events

There are no upcoming events at this time.

Twitter


Congratulations #ARTESiA Dr. Juan Benezet Mazuecos and Study Team on enrolling the 400th patient in the Spain!! We thank you for your continued support and dedication to the ARTESiA study! @PHRIresearch #Apixaban #SCAF https://t.co/ZtO4hWJyJx

Congratulations #ARTESiA Dr. Andrew Kaplan and Study Coordinators Adam Gitkin & Tawni Oyler on enrolling the 100th patient at their site!! We thank you for your continued support and dedication to the ARTESiA study!
@PHRIresearch #Apixaban #SCAF https://t.co/RzI5KqFFfy

Congratulations #ARTESiA Dr. Bastiaan Leonardus Kietselaer and Study Team on enrolling the 250th patient in the Netherlands!! We thank you for your continued support and dedication to the ARTESiA study! @PHRIresearch #Apixaban #SCAF https://t.co/LKUvuEcE2J

LinkedIn